RESUMEN
It is widely held that the spatial processing functions underlying rodent navigation are similar to those encoding human episodic memory (Doeller et al., 2010). Spatial and nonspatial information are provided by all senses including vision. It has been suggested that visual inputs are fed to the navigational network in cortex and hippocampus through dorsal and ventral intracortical streams (Whitlock et al., 2008), but this has not been shown directly in rodents. We have used cytoarchitectonic and chemoarchitectonic markers, topographic mapping of receptive fields, and pathway tracing to determine in mouse visual cortex whether the lateromedial field (LM) and the anterolateral field (AL), which are the principal targets of primary visual cortex (V1) (Wang and Burkhalter, 2007) specialized for processing nonspatial and spatial visual information (Gao et al., 2006), are distinct areas with diverse connections. We have found that the LM/AL border coincides with a change in type 2 muscarinic acetylcholine receptor expression in layer 4 and with the representation of the lower visual field periphery. Our quantitative analyses also show that LM strongly projects to temporal cortex as well as the lateral entorhinal cortex, which has weak spatial selectivity (Hargreaves et al., 2005). In contrast, AL has stronger connections with posterior parietal cortex, motor cortex, and the spatially selective medial entorhinal cortex (Haftig et al., 2005). These results support the notion that LM and AL are architecturally, topographically, and connectionally distinct areas of extrastriate visual cortex and that they are gateways for ventral and dorsal streams.
Asunto(s)
Vías Nerviosas/anatomía & histología , Receptor Muscarínico M2/metabolismo , Corteza Visual/anatomía & histología , Animales , Bisbenzimidazol/administración & dosificación , Corteza Entorrinal/anatomía & histología , Femenino , Inmunohistoquímica , Masculino , Ratones , Ratones Endogámicos C57BL , Microinyecciones , Corteza Motora/anatomía & histología , Lóbulo Parietal/anatomía & histología , Lóbulo Temporal/anatomía & histologíaRESUMEN
OBJECTIVE: To observe the peripheral and central neural connection of acupoint "Hegu" (LI4), "Neiguan" (PC6), "Futu" (LI18) and the thyroid gland (TG) region with fluorescence double-labelling method. METHODS: Thirty male Wistar rats were divided into LI4-LI18 group, PC6-LI18 group, TG-LI 18 group, LI 4-TG group, and PC 6-TG group, with 6 rats in each. Fluorescence dyes Propidium Iodide (PI, 10 microL) and Bisbenzimide (Bb, 10 microL) were, separately, injected into those acupoints mentioned above and the TG region. Sixty hours after PI-injection and 12 hours after Bb-injection, the rats under deep anesthesia were transcardiacally perfused with PBS containing 4% polyoxymethylene, followed by taking the spinal cord and dorsal root ganglia (DRGs) of the cervical segments (C1-C8) and thoracic 1 (T1) segment. Fluorescent single- and dual-labeled cells of the sliced DRGs and cervical spinal cord were observed by fluorescence microscope. RESULTS: (1) All PI- and Bb-labeled cells were found to distribute in DRGs from C1-T1 segments. PI single-labeled cells from LI4 and PC6 mainly distributed in DRGs from C4 to C8. Bb single-labeled cells from LI18 and TG region distributed in DRGs from C1-C6. (2) Dual-labeled cells in the LI 4-LI 188 group, PC6-LI18 group, LI4-TG group, and PC6-TG group distributed in DRGs from C3 to C7, suggesting bifurcate peripheral processes of the cervical DRG neurons to innervate LI8, LI4, PC6 and the TG region. And the dual-labeled cells of the TG-LI 18 group distributed mainly in DRGs from C1 to C4. (3) A small number of single-labeled neurons(about 8% of total labeled cells in DRGs) and only several dual-labeled neurons were found in the anterior horn of the cervical spinal cord. CONCLUSION: LI18, LI4 and PC6 and the thyroid gland have the same peripheral cells in DRGs of C3-C7 segments, suggesting that the bifurcate peripheral innervation may provide an anatomic evidence for the analgesic effect of acupuncture of LI18, LI4 and PC6 on thyroidectomy.
Asunto(s)
Puntos de Acupuntura , Neuronas Aferentes/química , Glándula Tiroides/química , Animales , Bisbenzimidazol/administración & dosificación , Bisbenzimidazol/química , Modelos Animales de Enfermedad , Colorantes Fluorescentes/administración & dosificación , Colorantes Fluorescentes/química , Masculino , Microscopía Fluorescente , Propidio/administración & dosificación , Propidio/química , Distribución Aleatoria , Ratas , Ratas Wistar , Glándula Tiroides/citologíaRESUMEN
The mitochondrion has been proposed to be both a target and a perpetuator of hepatic ischemia-reperfusion (IR) injury because of its reactive oxygen species (ROS) formation. Our hypothesis is that subcellular derangement in mitochondrial function is one of the earliest steps leading to the early IR-mediated loss of hepatocellular integrity. Under chloralhydrate anesthesia (36 mg/kg BW), Sprague-Dawley rats (n=7) were subjected to 40 min of warm hepatic lobular ischemia followed by 60 min reperfusion. Rats (n=7) without hepatic IR were used as controls. The fluorochromes rhodamine 123 and bisbenzimide were administered intravenously for observation of changes in mitochondrial membrane potential and hepatocellular viability, respectively. Intravital fluorescence microscopy (IVFM) was performed prior to ischemia and at 15, 45, and 60 min after reperfusion in the experimental group and at corresponding time points in the control group. A parallel relationship between mitochondrial membrane potential and cell viability as reflected in a concomitant reduction in nuclear and cytoplasmic fluorescence intensity during IR was demonstrated (r2=0.76, P<0.05). The diminution in fluorescence intensities also correlated significantly with the elevation in plasma transaminase activities (r2>0.90, P<0.05). Our data suggested that alteration in mitochondrial membrane potential is a critical subcellular event leading to hepatocellular damage in the early phase of hepatic IR injury.
Asunto(s)
Calor , Isquemia/fisiopatología , Hígado/irrigación sanguínea , Hígado/fisiopatología , Mitocondrias Hepáticas/fisiología , Daño por Reperfusión/fisiopatología , Animales , Bisbenzimidazol/administración & dosificación , Bisbenzimidazol/farmacología , Supervivencia Celular/efectos de los fármacos , Colorantes Fluorescentes/administración & dosificación , Colorantes Fluorescentes/farmacología , Inyecciones Intravenosas , Membranas Intracelulares/efectos de los fármacos , Membranas Intracelulares/fisiología , Isquemia/etiología , Hígado/patología , Pruebas de Función Hepática , Masculino , Potenciales de la Membrana/efectos de los fármacos , Distribución Aleatoria , Ratas , Ratas Sprague-Dawley , Especies Reactivas de Oxígeno/metabolismo , Rodamina 123/administración & dosificación , Rodamina 123/farmacología , Partículas Submitocóndricas/metabolismo , Factores de Tiempo , Transaminasas/sangreRESUMEN
(2S)-2-{[(3,5-Diflurophenyl)acetyl]amino}-N-[(3S)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]propanamide (compound E) is a gamma-secretase inhibitor capable of reducing amyloid beta-peptide (1-40) and amyloid beta-peptide (1-42) levels. In this study we investigated the effect of in vivo administration of compound E on guinea-pig plasma, CSF and cortical amyloid beta-peptide (1-40) concentration. Using repeated sampling of CSF, compound E (30 mg/kg p.o.) was shown to cause a time-dependent decrease in CSF amyloid beta-peptide (1-40) levels, which was maximal at 3 h (70% inhibition), compared to baseline controls. After 3 h administration, compound E (3, 10 and 30 mg/kg p.o.), reduced plasma, CSF and DEA-extracted cortical amyloid beta-peptide (1-40) levels by 95, 97 and 99%; 26, 48 and 78%; 32, 33, and 47%, respectively, compared to vehicle control values. In the same animals, compound E (3, 10 and 30 mg/kg p.o.) inhibited cortical gamma-secretase activity, determined ex vivo using the recombinant substrate C100Flag, by 40, 71 and 79% of controls, respectively. These data demonstrate the value of determining not only the extent by which systemic administration of a gamma-secretase inhibitor reduces amyloid beta-peptide, but also the inhibition of brain gamma-secretase activity, as a more direct estimate of enzyme occupancy.
Asunto(s)
Ácido Aspártico Endopeptidasas/metabolismo , Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/enzimología , Inhibidores de Proteasas/administración & dosificación , Administración Oral , Secretasas de la Proteína Precursora del Amiloide , Péptidos beta-Amiloides/metabolismo , Animales , Arsenicales/administración & dosificación , Bisbenzimidazol/administración & dosificación , Bisbenzimidazol/análogos & derivados , Relación Dosis-Respuesta a Droga , Endopeptidasas , Activación Enzimática/efectos de los fármacos , Activación Enzimática/fisiología , Cobayas , Masculino , Fragmentos de Péptidos/metabolismoRESUMEN
Nuclear delivery of extracellular DNA by nonviral vectors is inhibited by a series of cell membrane and compartmental barriers. Certain cationic amphiphiles that partition through cellular membranes to bind genomic DNA can enhance nuclear delivery of plasmid DNA. Specifically, delivering plasmid DNA complexed to the DNA-binding dye Hoechst 33258 produces cellular transfection levels similar to those achieved by cationic liposome:DNA complexes (CLDC), with less toxicity. Incorporating Hoechst into CLDC or polyethyleneimine:DNA complexes significantly increased reporter gene expression, as well as the percentage of cells transfected. Hoechst:CLDC significantly improved transfection of nondividing cells and efficiently transfected cells in the presence of anionic molecules that block cellular uptake of and transfection by CLDC alone. Hoechst:CLDC also increased gene expression in mouse tissues following intravenous delivery. Delivery of fluorescently labeled plasmid DNA via Hoechst altered its intracellular trafficking by both minimizing lysosomal sequestration and accelerating delivery into the nucleus. Agents such as Hoechst constitute a novel class of nonviral carriers that can confer their membrane-permeant properties on complexed DNA, thus redirecting its intracellular trafficking. In addition, binding of Hoechst 33258 to specific chromosomal DNA target sequences and its ability to modulate transcription may further enhance the expression of delivered genes.
Asunto(s)
Bisbenzimidazol/metabolismo , Núcleo Celular/metabolismo , Plásmidos/administración & dosificación , Transfección/métodos , Animales , Transporte Biológico/efectos de los fármacos , Bisbenzimidazol/administración & dosificación , Bisbenzimidazol/farmacología , Línea Celular , Permeabilidad de la Membrana Celular , Núcleo Celular/química , ADN/administración & dosificación , ADN/análisis , ADN/metabolismo , Expresión Génica , Genes Reporteros , Inyecciones Intravenosas , Liposomas/química , Liposomas/metabolismo , Luciferasas/análisis , Luciferasas/genética , Ratones , Ratones Endogámicos , Membrana Nuclear/efectos de los fármacos , Membrana Nuclear/fisiología , Plásmidos/química , Plásmidos/metabolismo , Polisacáridos/farmacología , Distribución TisularRESUMEN
When mouse L-cells were treated with a combination of 5-bromodeoxyuridine (BrdUrd) and Hoechst 33258, the metaphase chromosomes revealed under-condensation of the chromatin fibers in the sister centromeres. The application of the osmium-thiocarbohydrazide technique to the air-dried chromosome preparations made it possible to elucidate the ultrastructure of the under-condensed centromeric region at the level of the 30 nm chromatin fiber. Scanning electron microscopy revealed that the under-condensed region consisted of a coiled fiber with a diameter of about 400 nm, and a gyre diameter of approximately 600 nm. The coiled fiber was composed of the 30 nm chromatin fiber loops. These findings indicate that a continuous coiled structure, which is the final higher order structure of the condensed chromatin fiber, exists throughout the entire length of the mouse L-cell metaphase chromosome.
Asunto(s)
Bisbenzimidazol/farmacología , Bromodesoxiuridina/farmacología , Cromosomas/efectos de los fármacos , Animales , Bisbenzimidazol/administración & dosificación , Bromodesoxiuridina/administración & dosificación , Centrómero/efectos de los fármacos , Centrómero/ultraestructura , Cromatina/efectos de los fármacos , Cromatina/ultraestructura , Cromosomas/ultraestructura , Células L , Metafase , Ratones , Microscopía Electrónica de RastreoRESUMEN
DNA specific fluorochrome (Hoechst 33342 and 33258) as non-toxic stains, have been widely used to measure cell density and proliferation, detect sperm-egg fusion, and observe the development of pre-implantation embryos. It has been reported that Hoechst 33342 at a concentration of 10 micrograms ml-1 had significant inhibition on embryo cleavage. In this study, we incubated B6D2F1 mouse sperm and eggs with different concentrations of Hoechst 33258, 0, 1.0, 10.0, 20.0, 100 micrograms ml-1. We found that: (1) 100 micrograms ml-1 of H-33258 significantly decreased the sperm motility at 90 min and 4 h. (P less than 0.05), (2) 20 micrograms ml-1 and 100 micrograms ml-1 of Hoechst 33258 significantly inhibited mouse fertilization in vitro (P less than 0.05), and (3) 1.0 micrograms ml-1 and 10.0 micrograms ml-1 Hoechst 33258 had no effect on fertilization rate. But when we pre-incubated sperm at 10 micrograms ml-1 Hoechst 33258 for 90 min, and inseminated oocytes in the medium with same concentration of Hoechst 33258, the embryo cleavage was significantly inhibited.
Asunto(s)
Bisbenzimidazol/farmacología , Motilidad Espermática/efectos de los fármacos , Espermatozoides/efectos de los fármacos , Animales , Bisbenzimidazol/administración & dosificación , ADN/metabolismo , Desarrollo Embrionario y Fetal/efectos de los fármacos , Fertilización In Vitro , Masculino , Ratones , Espermatozoides/metabolismoRESUMEN
Pibenzimol is a fluorescent molecule known to bind to double stranded DNA. It also induces prolongation of the G2 phase of the cell cycle, inhibition of DNA replication and cessation of the growth of some cells in late S phase after DNA content has been doubled. It has been shown to increase the life span of mice bearing intraperitoneally implanted L1210 and P388 leukemia. These factors coupled with the affinity of pibenzimol for pancreatic tissue led us to conduct a phase I-II trial of pibenzimol hydrochloride in patients with advanced pancreatic cancer. Twenty-six patients were treated with a five day continuous infusion of pibenzimol at a dose ranging from 6-28 mg/m2/d. There were no treatment related deaths. Major toxicity was hyperglycemia which was self-limited. No objective responses were noted.
Asunto(s)
Bisbenzimidazol/uso terapéutico , Carcinoma Intraductal no Infiltrante/tratamiento farmacológico , Neoplasias Pancreáticas/tratamiento farmacológico , Adulto , Bisbenzimidazol/administración & dosificación , Bisbenzimidazol/efectos adversos , Bisbenzimidazol/sangre , Esquema de Medicación , Evaluación de Medicamentos , Enfermedades Gastrointestinales/inducido químicamente , Humanos , Hiperglucemia/inducido químicamente , Infusiones IntravenosasRESUMEN
Cultures of a cattle cell line and a Peromyscus eremicus cell line recovering from a pulse-treatment with mitomycin C, actinomycin D, 33258 Hoechst, and nitrosoguanidine exhibited translocations between chromosomes at the centromeric regions (Robertsonian fusions) as well as between centromere and telomere and between telomeres (tandem translocations). The frequency of Robertsonian fusions was found to be dose-dependent and duration-dependent with the mitomycin treatment. Biarmed chromosomes resulting from fusions may be monocentric or dicentric. Analyses of clones isolated from treated cells suggested that fused chromosomes may perpetuate in the cell populations.
Asunto(s)
Bovinos/genética , Ratones/genética , Translocación Genética/efectos de los fármacos , Animales , Bisbenzimidazol/administración & dosificación , Bisbenzimidazol/farmacología , Fusión Celular , Línea Celular , Cromosomas/ultraestructura , Células Clonales , Dactinomicina/administración & dosificación , Dactinomicina/farmacología , Relación Dosis-Respuesta a Droga , Metafase , Mitomicinas/administración & dosificación , Mitomicinas/farmacología , Nitrosoguanidinas/administración & dosificación , Nitrosoguanidinas/farmacologíaRESUMEN
The benzimidazole derivative Hoechst 33258 was added at various concentrations to human leukocyte cultures. After 16 or 24 h of treatment, with concentrations equal to or greater than 100 mug/ml of Hoechst 33258, a number of chromosomes showed regions in which the chromatin was undercontracted. The centromeric regions of chromosome 1 and, more rarely, of chromosomes 3 and 9 appeared to be decondensed. Short decondensed regions were also present on the long arms of chromosomes 1 and 2. The possible nature of these regions is discussed.